Missing data sensitivity analysis for recurrent event data using controlled imputation
Oliver N. Keene, James Roger, Benjamin F. Hartley et al. · Pharmaceutical Statistics · 2014
Statistical analyses of recurrent event data have typically been based on the missing at random assumption. One implication of this is that, if data are collected only when patients are on their randomized treatment, the resulting de jure estimator of treatment effect corresponds to the situation in which the patients adhere to this regime throughout the study. For confirmatory analysis of clinical trials, sensitivity analyses are required to investigate alternative de facto estimands that depart from this assumption. Recent publications have described the use of multiple imputation methods based on pattern mixture models for continuous outcomes, where imputation for the missing data for one treatment arm (e.g. the active arm) is based on the statistical behaviour of outcomes in another arm (e.g. the placebo arm). This has been referred to as controlled imputation or reference-based imputation. In this paper, we use the negative multinomial distribution to apply this approach to analyses of recurrent events and other similar outcomes. The methods are illustrated by a trial in severe asthma where the primary endpoint was rate of exacerbations and the primary analysis was based on the negative binomial model.
Cited by 47 works. doi:10.1002/pst.1624
Authors
References
- CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
- The Prevention and Treatment of Missing Data in Clinical Trials
- Multiple-Imputation Inferences with Uncongenial Sources of Input
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- Miscellanea. Small-sample degrees of freedom with multiple imputation
- Intent-to-Treat Analysis for Longitudinal Studies with Drop-Outs
- The Prevention and Treatment of Missing Data in Clinical Trials
- Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited
- Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials
- Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation